PA
OLMA icon

Profund Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Profund Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Sell
38,359
-20,218
-35% -$271K 0.01% 571
2026
Q1 		$873K Buy
58,577
+41,196
+237% +$917K 0.03% 385
2025
Q4 		$435K Buy
+17,381
New +$309K 0.01% 628
2025
Q1 		– Sell
-15,862
Closed -$92.5K – 1074
2024
Q4 		$92.5K Sell
15,862
-2,085
-12% -$20.8K ﹤0.01% 1073
2024
Q3 		$214K Sell
17,947
-961
-5% -$12.3K 0.01% 1014
2024
Q2 		$205K Sell
18,908
-26,310
-58% -$285K 0.01% 976
2024
Q1 		$512K Buy
+45,218
New +$583K 0.02% 567

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Profund Advisors's OLMA Position: Q2 2026 in Review

Profund Advisors reduced its Olema Pharmaceuticals (OLMA) stake by 35% in Q2 2026, selling an estimated $271K and leaving 38,359 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #571.

Profund Advisors first reported a position in OLMA in Q1 2024 and has held it in 7 quarters since. The position peaked at $873K in Q1 2026. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Profund Advisors held 38,359 shares of Olema Pharmaceuticals worth $480K as of Q2 2026.
  • Profund Advisors sold 20,218 Olema Pharmaceuticals shares in Q2 2026, an estimated $271K.
  • Olema Pharmaceuticals made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #571 holding.
  • Profund Advisors first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Profund Advisors's Olema Pharmaceuticals position peaked at $873K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.